Skip to main content
Log in

Establishment and characterization of xenograft models of human neuroblastoma bone metastasis

  • Original Paper
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Objects

To improve the therapy of advanced neuroblastoma (NB), it is critical to develop animal models that mimic NB bone metastases. Unlike the human disease, NB xenograft models rarely metastasize spontaneously to bone from the orthotopic site of primary tumor growth.

Methods

Single-cell suspensions of SY5Y, KCNR NB cells were injected directly into the femur of nude mice. Radiological and histological analyses and immunohistochemistry analyses were performed to characterize these osseous NB models. SY5Y and KCNR result in osteolytic responses.

Results

We have detected osteoprotegerin, receptor activator of nuclear factor kappa B ligand, parathyroid hormone-related protein, and endothelin-1, proteins associated with bone growth and osteolysis, and C-X-C chemokine receptor type 4 (CXCR4) involved in tumor growth and tumor cell migration in the NB cells grown in the bone.

Conclusions

These animal models can be used to study biological interactions, pathways, and potential therapeutic targets and also to evaluate new agents for treatment and prevention of NB bone metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Ara T, DeClerck YA (2006) Mechanisms of invasion and metastasis in human neuroblastoma. Cancer Metastasis Rev 25:645–657

    Article  PubMed  Google Scholar 

  2. Bilir A, Erguven M, Yazihan N, Aktas E, Oktem G, Sabanci A (2010) Enhancement of vinorelbine-induced cytotoxicity and apoptosis by clomipramine and lithium chloride in humanneuroblastoma cancer cell line SH-SY5Y. J Neurooncol 100:385–395

    Article  PubMed  CAS  Google Scholar 

  3. Carlisle AJ, Lyttle CA, Carlisle RY, Maris JM (2009) CXCR4 expression heterogeneity in neuroblastoma cells due to ligand-independent regulation. Mol Cancer 8:126

    Article  PubMed  Google Scholar 

  4. Dickey A, Schleicher S, Leahy K, Hu R, Hallahan D, Thotala DK (2011) GSK-3β inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell line. J Neurooncol 104:145–153

    Article  PubMed  CAS  Google Scholar 

  5. Dubois SG, Kalika Y, Lukens JN, Brodeur GM, Seeger RC, Atkinson JB, Haase GM, Black CT, Perez C, Shimada H, Gerbing R, Stram DO, Matthay KK (1999) Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol 21:181–189

    Article  PubMed  CAS  Google Scholar 

  6. Feng C, Zuo Z (2012) Regulatory factor X1-induced down-regulation of transforming growth factor β2 transcription in human neuroblastoma cells. J Biol Chem 287:22730–22739

    Article  PubMed  CAS  Google Scholar 

  7. Granchi D, Corrias MV, Garaventa A, Baglìo SR, Cangemi G, Carlini B, Paolucci P, Giunti A, Baldini N (2011) Neuroblastoma and bone metastases: clinical significance and prognostic value of Dickkopf 1 plasma levels. Bone 48:152–159

    Article  PubMed  CAS  Google Scholar 

  8. Granchi D, Garaventa A, Amato I, Paolucci P, Baldini N (2006) Plasma levels of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in patients with neuroblastoma. Int J Cancer 119:146–151

    Article  PubMed  CAS  Google Scholar 

  9. Hua Y, Gorshkov K, Yang Y, Wang W, Zhang N, Hughes DP (2012) Slow down to stay alive: HER4 protects against cellular stress and confers chemoresistance in neuroblastoma. Cancer. doi:10.1002/cncr.27496

  10. Kroesen M, Lindau D, Hoogerbrugge P, Adema GJ (2012) Immunocombination therapy for high-risk neuroblastoma. Immunotherapy 4:163–174

    Article  PubMed  Google Scholar 

  11. Li W, Chu Y, Zhang L, Yin L, Li L (2012) Ginsenoside Rg1 prevents SK-N-SH neuroblastoma cell apoptosis induced by supernatant from Aβ(1-40)-stimulated THP-1 monocytes. Brain Res Bull 88:501–506

    Article  PubMed  CAS  Google Scholar 

  12. Ma M, Ye JY, Deng R, Dee CM, Chan GC (2011) Mesenchymal stromal cells may enhance metastasis of neuroblastoma via SDF-1/CXCR4 and SDF-1/CXCR7 signaling. Cancer Lett 312:1–10

    Article  PubMed  CAS  Google Scholar 

  13. Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007) Neuroblastoma. Lancet 369:2106–2120

    Article  PubMed  CAS  Google Scholar 

  14. Matthay KK, George RE, Yu AL (2012) Promising therapeutic targets in neuroblastoma. Clin Cancer Res 18:2740–2753

    Article  PubMed  CAS  Google Scholar 

  15. Meier R, Mühlethaler-Mottet A, Flahaut M, Coulon A, Fusco C, Louache F, Auderset K, Bourloud KB, Daudigeos E, Ruegg C, Vassal G, Gross N, Joseph JM (2007) The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth, but not invasion. PLoS One 2:e1016

    Article  PubMed  Google Scholar 

  16. Owens C, Irwin M (2012) Neuroblastoma: the impact of biology and cooperation leading to personalized treatments. Crit Rev Clin Lab Sci 49:85–115

    Article  PubMed  CAS  Google Scholar 

  17. Park JR, Eggert A, Caron H (2008) Neuroblastoma: biology, prognosis, and treatment. Pediatr Clin North Am 55:97–120

    Article  PubMed  Google Scholar 

  18. Patel LR, Camacho DF, Shiozawa Y, Pienta KJ, Taichman RS (2011) Mechanisms of cancer cell metastasis to the bone: a multistep process. Future Oncol 7:1285–1297

    Article  PubMed  CAS  Google Scholar 

  19. Peng H, Sohara Y, Moats RA, Nelson MD Jr, Groshen SG, Ye W, Reynolds CP, DeClerck YA (2007) The activity of zoledronic acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation. Cancer Res 67:9346–9355

    Article  PubMed  CAS  Google Scholar 

  20. Poretti A, Grotzer MA (2012) Neuroblastoma with spinal cord compression: is there an emergency treatment of choice? Dev Med Child Neurol 54:297–298

    Article  PubMed  Google Scholar 

  21. Roodman GD (2004) Mechanisms of bone metastasis. N Engl J Med 351:195–196

    Article  CAS  Google Scholar 

  22. Sartelet H, Durrieu L, Fontaine F, Nyalendo C, Haddad E (2012) Description of a new xenograft model of metastatic neuroblastoma using NOD/SCID/Il2rg null (NSG) mice. In Vivo 26:19–29

    PubMed  Google Scholar 

  23. Sharp SE, Gelfand MJ, Shulkin BL (2011) Pediatrics: diagnosis of neuroblastoma. Semin Nucl Med 41:345–353

    Article  PubMed  Google Scholar 

  24. Sohara Y, Shimada H, DeClerck YA (2005) Mechanisms of bone invasion and metastasis in human neuroblastoma. Cancer Lett 228:203–209

    Article  PubMed  CAS  Google Scholar 

  25. Sohara Y, Shimada H, Scadeng M, Pollack H, Yamada S, Ye W, Reynolds CP, DeClerck YA (2003) Lytic bone lesions in human neuroblastoma xenograft involve osteoclast recruitment and are inhibited by bisphosphonate. Cancer Res 63:3026–3031

    PubMed  CAS  Google Scholar 

  26. Sorrentino S, Rosanda C, Parodi S, Rita Gigliotti A, Pasino M, Defferrari R, Paolo Tonini G, De Bernardi B (2012) Cyto-morphologic evaluation of bone marrow in infants with disseminated neuroblastoma. J Pediatr Hematol Oncol 34:154–158

    PubMed  Google Scholar 

  27. Sun W, Modak S (2012) Emerging treatment options for the treatment of neuroblastoma: potential role of perifosine. Onco Targets Ther 5:21–29

    PubMed  CAS  Google Scholar 

  28. Suva LJ, Washam C, Nicholas RW, Griffin RJ (2011) Bone metastasis: mechanisms and therapeutic opportunities. Nat Rev Endocrinol 7:208–218

    Article  PubMed  CAS  Google Scholar 

  29. Ishola TA, Chung DH (2007) Neuroblastoma. Surg Oncol 16:149–156

    Article  PubMed  Google Scholar 

  30. van Golen CM, Schwab TS, Kim B, Soules ME, Su Oh S, Fung K, van Golen KL, Feldman EL (2006) Insulin-like growth factor-I receptor expression regulates neuroblastoma metastasis to bone. Cancer Res 66:6570–6578

    Article  PubMed  Google Scholar 

  31. Yang S, Zheng J, Ma Y, Zhu H, Xu T, Dong K, Xiao X (2012) Oct4 and Sox2 are overexpressed in human neuroblastoma and inhibited by chemotherapy. Oncol Rep 28:186–192

    PubMed  Google Scholar 

  32. Zhang L, Yeger H, Das B, Irwin MS, Baruchel S (2007) Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma. Neoplasia 9:36–46

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by National Natural Science Foundation grant from China National Science Foundation Committee (project code 81172410).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hongyu Zhao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhao, H., Cai, W., Li, S. et al. Establishment and characterization of xenograft models of human neuroblastoma bone metastasis. Childs Nerv Syst 28, 2047–2054 (2012). https://doi.org/10.1007/s00381-012-1909-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-012-1909-3

Keywords

Navigation